No products in the cart.
Leuprorelin Acetate Microspheres Wholesale price comparison
$1.00
Leuprorelin Acetate Microspheres (Enantone®) is a sustained-release GnRH agonist formulation delivering 3.75?mg leuprorelin acetate in a pre-filled syringe. Manufactured by Takeda Pharmaceutical (Hikari Plant, Japan) and approved by NMPA under HJ20130660/HJ20130661, this product is ideal for laboratory research, including reproductive biology, prostate cancer models, endocrine signaling, and prolonged hormonal suppression studies.?? For laboratory research use only. Not for therapeutic, diagnostic, or veterinary application.?Please consult staff for other specifications and uses?
Description
Leuprorelin Acetate Microspheres Product Specifications
| Parameter | Detail |
|---|---|
| Product Name | Leuprorelin Acetate Microspheres Injection (Enantone®) |
| Generic Name | Leuprorelin (Leuprolide) Acetate |
| Synonyms | Lupron Depot, Eligard, Lupaneta, Lupride |
| CAS Number | 53714?56?0 |
| Formulation | Sustained-release PLGA microspheres in pre-filled syringe |
| Strength | 3.75?mg per syringe |
| Dosage Form | Injectable long-acting GnRH agonist |
| Approval Number | NMPA China: HJ20130660 / HJ20130661 |
| Manufacturer | Takeda Pharmaceutical Co., Ltd., Hikari Plant (Japan) |
| Storage | Refrigerate at 2–8?°C; protect from light |
| Intended Use | Laboratory/preclinical research only |
Leuprorelin Acetate Microspheres Mechanism of Action
Leuprorelin is a GnRH agonist that initially increases pituitary LH/FSH release, then induces receptor desensitization with continuous exposure—leading to sustained suppression of gonadotropins and downstream sex hormones .
Research Applications
Modeling prostate cancer or hormone?sensitive tumor growth & suppression ndi.fda.moph.go.th
Studies of endometriosis, uterine fibroids, precocious puberty, transgender hormone protocols
Reproductive and ART research involving ovarian suppression and hormone cycling
Pharmacokinetics & pharmacodynamics of sustained-release microsphere delivery systems
Pharmacokinetics & Safety Highlights
Clinical PK/PD studies report comparable Cmax/AUC and effective testosterone suppression with Enantone®
Sustained testosterone suppression to “castrate levels” observed within 2–4 weeks
Common side effects (based on clinical data): hot flashes, injection site discomfort, mood swings, headaches
Food and metabolic safety: reversible fertility suppression in animal models with no long-term pituitary damage
?? Research?Use Disclaimer
This product is exclusively intended for laboratory and preclinical research purposes. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Improper use may lead to health risks and regulatory violations.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 20 × 16 × 20 cm |
What can this be used to model?
Typical uses include prostate cancer suppression, endometriosis modeling, fertility research, and controlled hormonal shutdown in endocrine studies.
How quickly does hormonal suppression occur?
Research indicates testosterone castration levels within 2–4 weeks after a single dose of leuprorelin microspheres
Is this formulation sustained-release?
Yes. Enantone® provides prolonged drug release using PLGA microspheres, maintaining effective levels for up to 28–30 days .
What kind of safety data is available?
Clinical studies show a tolerable safety profile—common mild-to-moderate effects include hot flashes, injection site reactions, and mood alteration .
Related products
Dienogest Tablets 2mg × 28 Tablets (Changyining)
Dienogest Tablets (Changyining) contain 2mg of dienogest per tablet, formulated for laboratory and preclinical research focused on hormonal modulation, endometriosis models, and reproductive pharmacology.
$2.00
?? This product is strictly for research purposes only. Not for human, therapeutic, or diagnostic use.?Please consult staff for other specifications and uses?Carboprost Tromethamine Injection 250?µg/mL Wholesale price comparison
Carboprost Tromethamine (brand: Hongsheng) is a sterile, clear injectable prostaglandin F?? analogue at 250?µg/mL, produced by Changzhou Siyou Pharmaceutical with NMPA approval H20094183. This vial is ideal for preclinical studies involving uterine contractions, labor initiation, or hemorrhage models.
?? For laboratory research use only. Not for clinical, diagnostic, or veterinary application.
$1.00Human Placental Extract Solution 2ml × 20 Ampoules (RTP)
RTP Human Placental Extract (2ml × 20 ampoules per box) is a bioactive injectable solution derived from human placenta, intended for cellular regeneration, dermatological, and cosmetic biology research. Manufactured by Handan Kangye Pharmaceutical Co., Ltd., it is approved under NMPA license S13020002.
?? Strictly for laboratory and experimental use only. Not approved for human or veterinary use.?Please consult staff for other specifications and uses?
$2.00Atosiban Acetate Injection 37.5?mg / 5?mL vial – ZhouNingBao Wholesale price comparison
Atosiban Acetate Injection (ZhouNingBao®) is a clear, sterile injectable containing 37.5?mg atosiban acetate in 5?mL. Produced by Nanjing Haina Pharmaceutical Co., Ltd. under Chinese NMPA registration H20213190, this formulation is ideal for laboratory and preclinical studies, including uterine contraction inhibition and fertility research.
?? For laboratory research use only. Not for therapeutic, clinical, or veterinary applications.?Please consult staff for other specifications and uses?
$3.00
Reviews
There are no reviews yet.